SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-031674
Filing Date
2021-06-04
Accepted
2021-06-04 07:15:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ljpc-defa14a_20210721.htm DEFA14A 47564
2 GRAPHIC g3zoyyaxybzb000001.jpg GRAPHIC 82369
3 GRAPHIC g3zoyyaxybzb000002.jpg GRAPHIC 62697
  Complete submission text file 0001564590-21-031674.txt   248596
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36282 | Film No.: 21994853
SIC: 2836 Biological Products, (No Diagnostic Substances)